cell therapy
Natural killer cells: the next frontier for cancer treatment
July 11 by Leila Hawkins
Pharma IQ speaks to Cytovia Therapeutics about developing the next generation of cancer treatments
Keeping tabs on pharma: Landmark new drug approvals and Sanofi’s diversity push
April 05 by Leila Hawkins
Pharma IQ’s latest round-up has the latest drug approvals for Gilead and AstraZeneca
FDA braces for increase in cell and gene therapies
January 22 by Natasha TaylorBy 2020, the FDA expects to receive over 200 IND applications per year, with approvals reaching 20 per year in 2025
£50 Million Technology and Innovation Centre in Cell Therapy to come to London
December 05 by Pharma IQ NewsThe Technology Strategy Board has announced further details about its Technology and Innovation Centre in Cell Therapy. The new centre will support the development and commercialisation of cell...
Scale-Up and Manufacturing of Regenerative Medicine
September 28 by Amber ScorahWhen introducing a regenerative medicine cell based product to a commercial setting, there are a number of things to take into consideration to ensure a commercially viable and safe product for patien...
